Faculty
Faculty
Faculty
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Jeffrey S. BORER,M.D<br />
Biographical Sketch<br />
He is the Gladys and Roland Harriman Professor of Cardiovascular Medicine at Weill Cornell Medical<br />
College, where he also is Professor of Radiology and of Cardiothoracic Surgery, both in Cardiovascular<br />
Medicine, and, administratively, chairs the Section of Cardiovascular Pathophysiology and The Howard<br />
Gilman Institute for Valvular Heart Diseases.<br />
He received his undergraduate education at Harvard, his medical degree from Cornell, and his postgraduate<br />
training at the Massachusetts General Hospital and in the Cardiology Branch of the National<br />
Heart, Lung and Blood Institute of the NIH, where he subsequently established the Nuclear Cardiology<br />
service and served as its first Chief. He was a Senior Fulbright Hays Scholar and Glorney-Raisbeck Fellow<br />
in 1974-75 at Guy's Hospital, University of London, in London, England. In 1979, he returned to Cornell.<br />
Dr. Borer is Editor-in-Chief of Cardiology, one of the world's oldest peer-reviewed cardiovascular journals,<br />
and of Advances in Cardiology, and serves on the Editorial Boards of several major peer-reviewed<br />
journals. Since 1977 he has served continually as an Advisor/Consultant to the Cardio-Renal Division of<br />
the U.S.F.D.A., chairing the Cardio-Renal Advisory Committee for 3 separate terms, the last ending in<br />
2004. He has authored a book on regulatory aspects of cardiovascular drug development and consults<br />
regularly for the pharmaceutical and devices industries. From 1984 through 2005 he served continually as<br />
an Advisor to NASA. He was President of the New York Cardiological Society in 1990-91, President of the<br />
New York State Chapter of the American College of Cardiology from 1997 to 1999, member of the Board<br />
of Governors of the American College of Cardiology from 1997-2000, member of Board of Governors of<br />
the Society of Cardiac Angiography and Interventions from 1995 to 2000, and member of the Board of<br />
Trustees of the Certification Board of Nuclear Cardiology from 1996 to 2002. Currently, he is President of<br />
the Heart Valve Society of America. He has authored 4 books and authored or co-authored almost 400<br />
journal articles, reviews and chapters. His research achievements have included (1) establishment of the<br />
benefits of the drug, nitroglycerin, during acute myocardial infarction (1971-75); (2) development of realtime<br />
radionuclide cineangiography and its application during exercise (1976-1979); (3) development of<br />
non-invasive prognostic indices in patients with coronary artery and valvular diseases (1979-present); (4)<br />
exploration of the cellular and molecular bases of heart failure in regurgitant valvular diseases and other<br />
volume overload states (1984-present). He has received several peer recognitions including the<br />
Hans-Peter Krayenbeuhl Memorial Award of the International Society of Cardiology in 2002 and the Public<br />
Service Medal of the National Aeronautics and Space Administration in 1999.<br />
____________________________________________________________________________<br />
Jan BUCH<br />
1969 MD Copenhagen University. Denmark<br />
1969 ECFMG Exam (Educational Council for Foreign Medical Graduates).<br />
USA<br />
Specialist in internal medicine and cardiology from Copenhagen University<br />
1969-1987 Employed at various university hospitals in Copenhagen. Denmark<br />
- 10-11 years at the main cardiological service at the university, Rigshospitalet<br />
(including 6 years in invasive cardiology<br />
1987-1991 Medical Director. Pfizer, Denmark<br />
1992-1999 Senior Associate Medical Director. Norvasc Team, Pfizer International, HQ, New York<br />
1999-2001 Medical Director. Norvasc Team, Pfizer Pharmaceuticals Group<br />
2001-2003 Senior Medical Director. Norvasc Team, Pfizer Pharmaceuticals Group<br />
2003-2006 Senior Medical Director, Caduet/Norvasc Team, Pfizer Global Pharmaceuticals<br />
2006 Senior Medical Director/World Wide Team Leader - Cardiovascular, Metabolic and<br />
Endocrine. Pfizer Global Pharmaceuticals<br />
2007 Global Team Leader/Senior Medical Director - Global CVM Medical<br />
Group. Medical Division, Pfizer Inc